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Abstract We describe here an easy system for the production of mg amounts of the rabbit Ca*‘-ATPase SERCA la in the yeast S. cerevisiae. The 
protein is present in several membranes, including the plasma membrane of the yeast, in a native conformation. It can be purified by immunoprecip- 
itation and can be phosphorylated from ATP in a Ca2’-dependent manner. Using a temperature-sensitive secretion mutant strain, the fully active 
protein can also be obtained in secretory vesicles. 
Key words. 
1. Introduction 
The 1 lO,OOO-Da SR Ca2’-ATPase from skeletal muscle is a 
membrane protein that actively transports Ca2’ within the sar- 
coplasmic reticulum as a result of ATP hydrolysis. This P-type 
ATPase plays an essential role in muscle relaxation. Ca’+-ATP- 
ase from rabbit and chicken fast twich muscle has been ex- 
pressed mainly in mammalian cells [1,2], resulting in the de- 
scription of a number of mutations or chimeras with interesting 
properties (e.g. see [l-7]). However, a problem with this system 
is the relatively low yield of Ca”-ATPase expression, which 
barely suffices for detailed biochemical analysis. More recently, 
the SR Ca”-ATPase has been expressed in the baculovirus/Sf9 
system [8]. Another good and cheap alternative for large scale 
production of foreign membrane proteins (e.g. [9-l l]), includ- 
ing ATPases (e.g. [12]) is the yeast S. cerevisiue. 
We describe here a procedure with the potential for produc- 
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Abbreviations: SR, sarcoplasmic reticulum; SERCA, sarco(endo)- 
plasmic reticulum Ca”-ATPase; PM, plasma membrane; C,,E,, octa- 
ethyleneglycol monododecylether; TES, 2-{[2-hydroxy-l,l-bis(hy- 
droxymethyl)ethyl]amino}ethanesulfonic acid;PBS, plasmid bluescript 
(Stratagene); MOPS, 3-[N-morpholino]propanosulfonic a id; EGTA, 
ethyleneglycol-bis-(-amino-ethyl ether) N,N’-tetra-acetic acid; pAb, 
polyclonal antibody; SDS, sodium dodecyl sulfate; PAGE, poly- 
acrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; TCA, 
trichloroacetic acid; FITC, fluorescein isothiocyanate; ATP, adenosine- 
5’-triphosphate; NADH, nicotinamide adenine dinucleotide, reduced 
form; RT-PCR, reverse transcriptase-polymerase chain reaction, 
DAPI, 4’,6-diamidino-2-phenylindole. 
tion of mg amounts of the native and fully active rabbit Ca2’- 
ATPase SERCA. 
2. Material and methods 
2.1. Plasmidic constructions and yeast cultures 
2.1. I. Yeast expression vector. The yeast expression vector pYeDPl1 
8-10 was a gift of Dr. D. Pompon [9]. Inserted cDNA was placed under 
the control of a GAL10 promoter and a PGK (phosphoglycerate ki- 
nase) terminator. 
2.1.2. CaZ’-ATPase cDNA isolation. Part of the skeletal muscle 
Ca’+-ATPase cDNA was isolated as previously described [13] by 
screening a rabbit neonatal skeletal muscle cDNA library constructed 
in a /2Zap II vector (Stratagene). The bluescript plasmid DNA was 
excised from the selected clone by co-infection with the helper phage 
R408. RT-PCR was performed on total RNA from adult rabbit skeletal 
muscle to obtain missing 5’ and 3’ coding regions. DNA fragments 
obtained by both screening and RT-PCR were ligated at the appropri- 
ate sites to obtain the full-length coding cDNA which was inserted at 
the SpeI and ApaI sites of the PBS II KS vector (Stratagene). The DNA 
was sequenced on both strands using the Sequenase Kit (United States 
Biochemicals). The amino acid sequence obtained was identical to the 
sequence of the adult isoform published by Brand1 et al. [14,15]; only 
a few silent mutations were observed at the nucleotide level. 
2.1.3. Insertion of Cd+-ATPase cDNA in pYeDPlI8-IO. Ca”-ATP- 
ase cDNA was inserted in EcoRIlSacI cloning sites of PBS. The cDNA 
was first modified by addition of an EcoRI site in the 5’ end by use of 
EcoRI linker. Using the Sac1 linker, a unique Sac1 restriction site was 
added to the 3’-terminus of the cDNA. Ca*‘-ATPase cDNA was then 
excised from PBS by double digestion with EcoRI and Sac1 and ligated 
to pYeDPl/S-10 at the same sites. 
2.1.4. Yeast strains, transformation and culture. Saccharomyces cere- 
visiae W303.1B (a, leu2, his3, trpl, ura3, ade2-1, canR, cyr’) was trans- 
formed according to the method described in [16]. Transformant selec- 
tion (based on ura3 complementation) and culture were performed as 
previously described [17]. To induce heterologous Cal’-ATPase ex- 
pression, a preculture was made in glucose medium until the OD 
reached 2 at 660 nm and the cells were then diluted to 0.1 OD in 
galactose medium. The cells, shaken at 3O”C, were harvested after 
1620 h. 
Temperature-sensitive Saccharomyces cerevisiae NY 17 (a, ura 3, 
sec64) [18] was transformed and selected as indicated above. Precul- 
tures and cultures were made at 25°C and the yeast was then submitted 
to a final heat-shock at 37°C for 2 h before harvesting, allowing the 
accumulation of secretory vesicles. 
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2.2. Total extract, microsome, plasma membrane and secretory vesicle 
preparation 
2.2.1. Cell homogenization. Yeasts were pelleted and resuspended in
10 ml of ice-cold ‘break’ buffer (50 mM TES-KOH. uH 7.5, 0.6 M 
sorbitol, 5 mM EDTA, 1 mM E‘GTA, 100 j&ml bacitracin, 1 mM 
benzamidine, 1 mM PMSF and 10 @ml trypsin inhibitor). The cells 
were homogenized with glass beads, shaken either manually or with a 
BeadBeader cell disrupter (Biospec). For preparation of yeast total 
protein extract, aliquots corresponding to 5 OD were taken out after 
the first resuspension, pelleted, resuspended in 2% TCA and homoge- 
nized with glass beads. 
2.2.2. Preparation of microsomes. plasma membranes and secretory 
vesicles. Microsomal fractions were prepared immediately after cell ho- 
mogenization, as described in [17]. Plasma membranes were purified by 
selective pH precipitation [19], followed in some cases by a discontin- 
uous density gradient centrifugation step. A total membrane fraction 
was prepared by the same procedure [19] without selective pH precipi- 
tation. Secretory vesicles were prepared according to [20] except that 
the final S-1000 Sephacryl step was omitted. For control experiments, 
rabbit skeletal muscle sarcoplasmic reticulum vesicles were prepared as 
described in [21]. 
2.2.3. Protein concentration determination. Protein concentrations 
were determined either by the Lowry method [22] or with bicinchoninic 
acid [23] using bovine serum albumin as a standard. 
2.3. Immune-detection and purification of expressed protein 
2.3.1. Immunoblotting. Proteins separated by SDS-PAGE [24] were 
either revealed by Coomassie blue staining or electrotransferred onto 
PVDF membranes [25]. For immunodetection, different polyclonal an- 
tibodies raised against the fast twich muscle SR Ca2’-ATPase were 
used. pAb 78(7), 79(A) and 79(B), which have been described in [26], 
are directed against the entire molecule, whereas pAb (809-827) de- 
scribed in [27] is directed against the peptide 809-827. After further 
incubation with “S-labelled protein A, immunoreactive proteins were 
revealed by exposing PVDF membranes to X-Omat film or using a 
PhosphorImager detector (Molecular Dynamics). 
2.3.2. Immunoprecipitation of Cd+-ATPase. Immunopurification of 
heterologously expressed Ca’+-ATPase was performed after membrane 
solubilization with C,,E,, essentially as described in [8] except hat the 
polyclonal antibody 79(B) was used. 
2.3.3. Immunolocalization of expressed Cd’-ATPase in yeast 
cells.. Yeasts were grown as indicated above and after induction of 
expression we proceeded as indicated in [28]; basically, the yeasts cells 
were fixed with 3.5% formaldehyde, washed, and spheroplasts, ob- 
tained by digestion with zymoliase, were labelled with the pAb 79(B) 
and visualized with FITC-conjugated secondary antibody. 
2.4. Phosphoenzyme formation 
Phosphoenzyme formation during ATP hydrolysis was carried out 
using immunopurified Ca”-ATPase linked to protein A-Sepharose- 
DAb complex. Phosnhorvlation was Derformed for 10 s in an ice-cold 
Solution dontainingr 20 r&M MOPS--KOH (pH 7.0), 80 mM KCl, 10 
mM NaN,. 1 mM M&l,. 2 uM IY-~*P~ATP and either 100 uM CaCl, 
or 2 mM’kGTA [29i A?te; addytion bf Laemmli buffer to stop the 
reaction and solubilize the membranes, samples were fractionated on 
SDS-PAGE and the E-“P intermediate was visualized with a 
PhosphorImager detector. 
2.5. ATPase activity 
ATPase activity was measured using a coupled enzyme assay, as 
described in [30]. -The reaction buffer (<S ml) contained; 10 mM TES- 
Tris (pH 7.5), 1 mM MgCl,, 5 mM Mg-ATP, 0.1 mM CaCl,, 1 mM 
phosphoenolpyruvate, 0.15 mM NADH, 0.1 mg/ml pyruvate kinase, 
0.1 mg/ml lactate dehydrogenase and 1 mg/ml C,,E,. We also added 
5 mM NaN,. 0.2 mM molvbdate. 0.05 mM ouabain and 50 mM KNO, 
to the reaction mixture; to inhibit F,F,-ATPases, phosphatases, 
Na’,K’-ATPases and pyrophosphatases, respectively. 
3. Results 
3.1. Rabbit Cd’-ATPase is expressed in yeast membranes 
Yeasts were transformed with plasmid pYeDPlW-10 [9], con- 
taining the rabbit Ca*‘-ATPase cDNA insert, and the expres- 
sion of protein was followed by SDS-PAGE and Western blot 
analysis (Fig. 1). A single band at 110 kDa was revealed by two 
different polyclonal antibodies specific for the rabbit fast twich 
skeletal muscle Ca*‘-ATPase, 78(7) (Fig. lA, lane 5) and 809- 
827 (Fig. lA, lane 7), at the same position as the SR Ca*‘- 
ATPase control (Fig. lA, lane 1). It is interesting to note that 
Ab 78(7), raised against the complete SR Ca*‘-ATPase, mainly 
recognizes the N-terminal half of the protein, while Ab 809-827 
was raised against he synthetic peptide Phe809-Pro827, located 
in the C-terminal half of the Ca*‘-ATPase. Immunological data 
thus indicate that the full-length polypeptide has been synthe- 
sized. No immunoreactive band was observed with these pAbs 
in total extracts from yeasts containing wild-type pYeDP, 
showing that the xpression is specifically related to the pres- 
ence of SERCA 1 cDNA (Fig. lA, lanes 4 and 6). Moreover, 
induction by galactose was necessary for Ca”-ATPase expres- 
sion since no band at 110 kDa was detected when the culture 
was carried out in glucose-containing medium (data not 
shown). 
Fractionation of the yeast membranes into microsomes and 
plasma membranes, following published procedures [17,191, in- 
dicated that heterologously synthesized Ca*‘-ATPase was re- 
covered in the plasma membrane fraction (Fig. lA, lanes 9 and 
1 l), and, to a lesser extent in the microsomes (Fig. lA, lane 8): 
despite similar amounts of membrane proteins loaded in the 
microsomes and plasma membranes lanes the signal from the 
antibodies was weaker in the case of microsomes. The mito- 
chondrial fraction was also tested by immunoblotting, and no 
Ca*‘-ATPase was present there (data not shown). 
The targetting of SERCA Ca*‘-ATPase to the yeast plasma 
membrane was further assessed by the use of differential abel- 
ing with antibodies specific for the yeast H’-ATPase, which is 
located in the plasma membrane: after linear sucrose gradient 
centrifugation of the total membranes and Western blotting of 
each fraction, the localization of Ca*‘-ATPase and H’-ATPase 
appeared similar, sedimenting mainly in the high density region 
of the gradient (Fig. 2A), as expected for the plasma membrane 
[3 11. A minor peak at 30% sucrose probably represents internal 
membranes. Immunolocalization experiments on yeast cells 
(Fig. 2B) showed that, although a significant part of Ca*‘- 
ATPase was located in membranes surrounding the nucleus, 
the enzyme was also present in secretory vesicles and in the 
plasma membrane. 
Comparison of the Western blot signals from the Ca*‘- 
ATP-ase expressed in yeast (lanes 411 in Fig. 1A) with differ- 
ent amounts of Ca”-ATPase from rabbit sarcoplasmic reticu- 
lum (lanes l-3 in Fig. 1A) shows that the expressed Ca*‘- 
ATPase is only a minor fraction of the total amount of protein. 
In the case of yeast total extract, Ca*‘-ATPase represent about 
0.1% of the proteins, i.e. a total of 900 pg of Ca*‘-ATPase per 
liter of culture. In plasma membranes, this percentage rises to 
-0.3%. 
3.2. Rabbit Cd’-ATPase expressed in yeast is active 
Despite its clear expression, the Ca*‘-ATPase band (110 
kDa) cannot easily be identified by the Coomassie blue staining 
of a sample of plasma membranes: this is due to the low per- 
centage of the expressed Ca*‘-ATPase compared to the large 
amount in these membranes of two major endogenous proteins 
of similar mass, the H’-ATPase (105 kDa) and the associated 
glycoprotein (115 kDa) [32] (Fig. lB, lanes 9-l 1). Probably for 
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the same reason we could not convincingly measure stimulation 
by Ca*’ of total ATPase activity or phosphorylation from 
[Y-~*P]ATP in yeast plasma membrane containing rabbit 
Ca*‘-ATPase. Nevertheless, the overall conformation of ex- 
pressed Ca*‘-ATPase seems to be similar to that of active SR 
Ca*+- ATPase: proteolytic digestion of the yeast plasma mem- 
brane by trypsin or protein radiolysis by y-rays [33,34] yielded 
fragments identical to those of the native SR, as revealed by 
Western blotting (data not shown). These results are in favour 
of a correct folding of the heterologously expressed protein in 
the plasma membrane. 
To demonstrate Ca*‘-ATPase activity we followed two kinds 
of strategies. In the first one, we purified Ca*‘-ATPase by 
membrane solubilization with C,,E, and immunoprecipitation. 
Fig. 3A shows that, after gel-electrophoresis, the immunopre- 
cipitate prepared from yeast expressing Ca*‘-ATPase presents 
a distinct Coomassie blue-staining band at 110 kDa (Fig. 3A, 
lanes 5 and 6), which is absent when immunoprecipitation is 
performed from total membranes of yeast not containing the 
Ca*‘-ATPase cDNA (Fig. 3A, lanes 3 and 4). Inununopurifica- 
tion also allowed us to observe a calcium-dependent phospho- 
rylation of yeast-expressed Ca*‘-ATPase: Ca”-ATPase was 
phosphorylated from [Y-~‘P]ATP in the presence of 100 PM 
Ca*’ (Fig. 3B, lane S), whereas phosphorylation was inhibited 
in the presence of 2 mM EGTA (Fig. 3B, lane 6). With control 
yeast no phosphorylation was observed, either in Ca*’ or in 
EGTA (Fig. 3B, lane 3 and 4). A similar irnmunopurification 
procedure performed with SR Ca*‘-ATPase, also yielded a 
Coomassie blue-stained band at 110 kDa (Fig. 3A, lanes 1 and 
2), which could be phosphorylated in the presence of Ca*’ 
(Fig. 3B, lane l), but not in EGTA (Fig. 3B, lane 2). 
In the second approach, Ca*‘-ATPase was expressed in a 
yeast mutant strain altered in the secretory pathway (set mu- 
tant), allowing the accumulation of secretory vesicles enriched 
in Ca*‘-ATPase. The percentage of Ca”-ATPase expressed in 
the vesicle fraction was measured to be about 0.6% of the 
protein content, i.e. larger than in the plasma membrane frac- 
tion (0.3%, see above). As shown in Fig. 4, the kinetics of ATP 
hydrolysis of vesicles containing the expressed Ca*+-ATPase 
(trace b) clearly reveal an ATPase activity which is Ca*‘- 
dependent and inhibited by the specific inhibitor of SR Ca*‘- 
ATPase, thapsigargin. Vesicles prepared from control yeast do 
not display such dependence (trace a). In addition, the differ- 
ence between control and Ca*‘-ATPase containing vesicles 
Fig. 1. Expression of rabbit SR Ca2’-ATPase in yeast. Yeast containing 
either the Ca’+-ATPase cDNA inserted in the pYeDP1/8-10 vector or 
the pYeDP118-10 vector without insert (control) were grown in a galac- 
tose culture medium. Total protein extract from yeast was obtained by 
cell disruption in the presence of TCA (lanes 67); microsomes (lane 
8) and plasma membranes before or after discontinuous ucrose gradi- 
ent purification (lanes 9-l 1, PM or PM control without Car’-ATPase 
cDNA insert) were prepared as described in section 2. Proteins of these 
various preparations and of rabbit skeletal sarcoplasmic reticulum 
(lanes 1-3, SR) were separated by 7.5% SDS-PAGE. Gels were either 
(A) transferred to PVDF membranes and probed with two kinds of 
antibodies, 78(7) (lanes l-5 and 8-l 1) or 809-827 (lanes 6 and 7), or 
(B) stained with Coomassie blue. The following amounts of protein 
were loaded in the wells: lane 1,0.5 pg; lane 2,0.1 pg; lane 3,O.Ol pg; 
lane4-7, -75pg; lane 8, 18pg; lane9,16pg; lane 10,5pg; lane 11,8 pg. 
Note that some proteolysis occured in lane 8. 
119 
(Fig. 4, trace c) is quite similar to ATP hydrolysis by SR Ca”- 
ATPase (Fig. 4, trace d) when the latter is present at the same 
concentration as that of expressed Ca*‘-ATPase (as estimated 
by immunodetection). Under the assay conditions used here 
(30°C 1 mg/ml C,,E,) the specific activity of expressed 
Ca*‘-ATPase was 21 f 5 pmoVmg/min (based on a calculated 
20% error in the quantitation of the expressed protein by West- 
ern blotting), while the specific activity of SR was 16 pmoYmg/ 
min. We thus conclude that rabbit Ca*‘-ATPase expressed in 
yeast is fully active. 
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Fig. 2. Localization of heterologous SR Ca”-ATPase in yeast. (A) Distribution of expressed Ca”-ATPase and endogenous H’-ATPase in sucrose 
gradient fractions of yeast membranes. Total membranes were isolated from yeast expressing rabbit SR Ca2+-ATPase and loaded on a linear 20-53% 
sucrose gradient. After an overnight centrifugation, 1 ml fractions were collected from the top of the gradient. The protein concentration f each 
fraction was measured and expressed as relative percentage (*). Western blots of 20 ~1 aliquots of gradient fractions were stained with antibodies 
against rabbit Ca*‘-ATPase or yeast H’-ATPase. After further incubation with “S-labelled protein A, immunoreactive proteins were revealed and 
the radioactivity of each ATPase band measured with a PhosphorImager detector. The radioactivity increased linearly with increasing amounts of 
membranes preparation loaded on the gel. As for total protein content of the gradient, the amount of Ca*+-ATPase (0) and H’-ATPase (A) are 
expressed as relative percentage. (B) Immunocytolocalization of heterologous SR Ca”-ATPase in yeast cells. Fluorescence images of a control yeast 
cell (1 and 2) and of a yeast cell expressing SR Ca*‘-ATPase (3 and 4). Cells were DAPI-stained for nuclei (2 and 4) or immunolabelled with pAb 
79 (B) against Ca*+-ATPase (1 and 3). 
t 
4. Discussion 
We have shown here that the Ca*‘-ATPase cDNA inserted 
in the yeast vector pYeDPl&10 containing a GAL promoter 
allowed heterologous expression of rabbit Ca*‘-ATPase in Sac- 
charomyces cerevisiae. The whole protein was expressed cor- 
rectly folded, as suggested by immunological results, and it was 
active, as demonstrated by phosphorylation from [Y-~*P]ATP 
and by the observation that Ca’+-ATPase specific activity was 
quite similar to the one measured in sarcoplasmic reticulum. 
We have also obtained indirect evidence for in vivo activity of 
the heterologous enzyme; in separate xperiments (not reported 
here), performed with a different yeast strain (RS-72) and ex- 
pression vector (pYE351) [35], where Ca*‘-ATPase cDNA was 
cloned under the control of the constitutive and powerful 
PMAI promoter, we failed to obtain stable Ca*‘-ATPase ex- 
pression but did observe transient expression: yeast grew very 
slowly and died after a few generations, suggesting that Ca*‘- 
ATPase over-expression may induce a toxic effect. This toxicity 
might arise because of an over-excretion of Ca*’ from the yeast 
cytosol or, more likely, from an indirect effect such as an in- 
creased pH inside the cell [36]. We are currently investigating 
this hypothesis. 
When the plant plasma membrane H’-ATPase is expressed 
in Saccharomyces cerevisiae it was found to be localised to the 
endoplasmic reticulum [35]. We initially expected to find the 
Ca*‘-ATPase in the same location, which is also its natural 
location in mammalian cells. As reported here, we found that 
the heterologously expressed Ca2’-ATPase was localized in 
several membranes, including the plasma membrane of the 
yeast. In the case of H’-ATPase from plant expressed in yeast, 
the C-terminal sequence was found to play an important role, 
resulting in the targetting of the heterologous protein to the 
endoplasmic reticulum [12]. By contrast, the N-terminal do- 
main of the endogenous yeast H’-ATPase is required for the 
functional insertion of the enyme into the plasma membrane 
[37]. It is a current challenge to understand the mechanism 
which directs a membrane protein to a given type of membrane 
(see e.g. [38]). 
Using the pYeDP plasmid with GAL10 promoter, Ca*‘- 
ATPase is expressed in relatively low amounts (about 0.1% of 
the total proteins) and this may well be the reason why the yeast 
can tolerate the protein. Despite this low percentage, the total 
amount that can be produced is quite substantial since about 
1 mg can be obtained per liter of culture. Moreover, the combi- 
nation of GAL10 promoter and set mutant enables us to purify 
secretory vesicles useful for functional studies. Immunopurifi- 
cation can be successfully applied but we are currently develop- 
ing easier purification schemes such as those based on the 
addition of a C- or N-terminal poly-histidine cluster to the 
expressed protein [39]. 
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Fig. 3. Immunopurification of Ca”-ATPase (A) and phosphoenzyme 
formation (B). About 1 mg of total membrane from yeast, expressing 
or not SR Cal+-ATPase, or 10 mg of SR were solubilized by incubation 
in C,,E,/azolectin in a ratio of 5:l. Solubilization was performed for 
1 h at 4°C at a ratio of total protein to C,,E, of 1:5. After immunopre- 
cipitation [8], the complexes were resuspended in a buffer containing 
2 PM [y-“P]ATP and either 100pM CaCl, or 2 mM EGTA and loaded 
on SDS-PAGE (see section 2). The gel was Coomassie blue-stained (A) 
and the radioactivity revealed using a PhosphorImager (B). 
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Fig. 4. ATPase activity of yeast secretory vesicles and sarcoplasmic 
reticulum. Experimental conditions were described in section 2. The 
different traces correspond to: (a) 50 pg of secretory vesicles fraction 
purified from control yeast; (b) 50 pg of secretory vesicles fraction 
purified from yeast expressing the Ca”-ATPase. This corresponds to 
320 ? 60 ng of Car’-ATPasekxpressed, as estimated by quantitative 
Western blotting: (c) is the difference between (b) and (a) +0.35; the 
arbitrary addition bf 0.35 allows a direct comparison in‘the ordinate; 
(d) 320 ng of Car’-ATPase from sarcoplasmic reticulum. At times 
indicated by a pulse, 0.2 mM EGTA, 0.2 mM CaCl, and 0.1 pg thapsi- 
gargin were successively added. 
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